Gene · 6612
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy. | Acta Pharm Sin B | 2023 | 38045051 | PubTator, text mining | PubMed |
| DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies. | J Cell Sci | 2023 | 37997922 | PubTator, text mining | PubMed |
| Single-cell sequencing and transcriptome analyses in the construction of a liquid-liquid phase separation-associated gene model for rheumatoid arthritis. | Front Genet | 2023 | 37953920 | PubTator, text mining | PubMed |
| A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment. | Cell Rep Med | 2023 | 37951217 | PubTator, text mining | PubMed |
| Distinct Mitotic Functions of Nucleolar and Spindle-Associated Protein 1 (NuSAP1) Are Controlled by Two Consensus SUMOylation Sites. | Cells | 2023 | 37947624 | PubTator, text mining | PubMed |
| CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling. | Front Immunol | 2023 | 37942327 | PubTator, text mining | PubMed |
| ZMYM2 controls human transposable element transcription through distinct co-regulatory complexes. | Elife | 2023 | 37934570 | PubTator, text mining | PubMed |
| Japanese encephalitis virus perturbs PML-nuclear bodies by engaging in interactions with distinct porcine PML isoforms. | Front Cell Infect Microbiol | 2023 | 37928180 | PubTator, text mining | PubMed |
| SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer. | Signal Transduct Target Ther | 2023 | 37925421 | PubTator, text mining | PubMed |
| Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer. | Cells | 2023 | 37887339 | PubTator, text mining | PubMed |
| Molecular mechanism of vimentin nuclear localization associated with the migration and invasion of daughter cells derived from polyploid giant cancer cells. | J Transl Med | 2023 | 37833712 | PubTator, text mining | PubMed |
| A noncanonical function of SKP1 regulates the switch between autophagy and unconventional secretion. | Sci Adv | 2023 | 37831778 | PubTator, text mining | PubMed |
| Exploration of SUMO2/3 Expression Levels and Autophagy Process in Fragile X-Associated Tremor/Ataxia Syndrome: Addressing Study Limitations and Insights for Future Research. | Cells | 2023 | 37830578 | PubTator, text mining | PubMed |
| SifA SUMOylation governs Salmonella Typhimurium intracellular survival via modulation of lysosomal function. | PLoS Pathog | 2023 | 37773952 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma. | Theranostics | 2023 | 37771771 | PubTator, text mining | PubMed |
| Biophysical characterization of the cetacean morbillivirus haemagglutinin glycoprotein. | Virus Res | 2023 | 37769814 | PubTator, text mining | PubMed |
| Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model. | Cells | 2023 | 37759532 | PubTator, text mining | PubMed |
| SUMOylation indirectly suppresses activity of the HIF-1α pathway in intestinal epithelial cells. | J Biol Chem | 2023 | 37742924 | PubTator, text mining | PubMed |
| SENP6 regulates localization and nuclear condensation of DNA damage response proteins by group deSUMOylation. | Nat Commun | 2023 | 37735495 | PubTator, text mining | PubMed |
| ERα promotes SUMO1 transcription by binding with the ERE and enhances SUMO1-mediated protein SUMOylation in breast cancer. | Gland Surg | 2023 | 37727335 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6612/papers?page=4